Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Heterogeneity of the action potential duration is required for sustained atrial fibrillation
Uma Mahesh R. Avula, Jeffrey Abrams, Alexander Katchman, Sergey Zakharov, Sergey Mironov, Joseph Bayne, Daniel Roybal, Anirudh Gorti, Lin Yang, Vivek Iyer, Marc Waase, Deepak Saluja, Edward J. Ciaccio, Hasan Garan, Andrew R. Marks, Steven O. Marx, Elaine Y. Wan
Uma Mahesh R. Avula, Jeffrey Abrams, Alexander Katchman, Sergey Zakharov, Sergey Mironov, Joseph Bayne, Daniel Roybal, Anirudh Gorti, Lin Yang, Vivek Iyer, Marc Waase, Deepak Saluja, Edward J. Ciaccio, Hasan Garan, Andrew R. Marks, Steven O. Marx, Elaine Y. Wan
View: Text | PDF
Research Article Cardiology Cell biology

Heterogeneity of the action potential duration is required for sustained atrial fibrillation

  • Text
  • PDF
Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia and accounts for substantial morbidity and mortality. Recently, we created a mouse model with spontaneous and sustained AF caused by a mutation in the NaV1.5 channel (F1759A) that enhances persistent Na+ current, thereby enabling the investigation of molecular mechanisms that cause AF and the identification of potentially novel treatment strategies. The mice have regional heterogeneity of action potential duration of the atria similar to observations in patients with AF. In these mice, we found that the initiation and persistence of the rotational reentrant AF arrhythmias, known as spiral waves or rotors, were dependent upon action potential duration heterogeneity. The centers of the rotors were localized to regions of greatest heterogeneity of the action potential duration. Pharmacologically attenuating the action potential duration heterogeneity reduced both spontaneous and pacing-induced AF. Computer-based simulations also demonstrated that the action potential duration heterogeneity is required to generate rotors that manifest as AF. Taken together, these findings suggest that action potential duration heterogeneity in mice and humans is one mechanism by which AF is initiated and that reducing action potential duration heterogeneity can lessen the burden of AF.

Authors

Uma Mahesh R. Avula, Jeffrey Abrams, Alexander Katchman, Sergey Zakharov, Sergey Mironov, Joseph Bayne, Daniel Roybal, Anirudh Gorti, Lin Yang, Vivek Iyer, Marc Waase, Deepak Saluja, Edward J. Ciaccio, Hasan Garan, Andrew R. Marks, Steven O. Marx, Elaine Y. Wan

×

Figure 2

Inhomogeneity of TG NaV1.5 expression and persistent Na+ current in F1759A-dTG mice.

Options: View larger image (or click on image) Download as PowerPoint
Inhomogeneity of TG NaV1.5 expression and persistent Na+ current in F175...
(A) Representative immunofluorescent images of atrial cardiomyocytes isolated from littermate control mice and F1759A-dTG mice. Atrial cardiomyocytes were permeabilized and incubated with or without anti-FLAG antibody and with FITC-conjugated secondary antibody. Images were obtained with confocal microscopy at ×20 (left) and ×40 original magnification (right). Scale bars: 100 μm. (B) Graph quantifying immunofluorescent intensity using ImageJ (NIH). Mean ± SEM. **P < 0.01, 2-tailed Student’s t test; n = 3 mice for each group, control and F1759A-dTG. M1, mouse 1; M2, mouse 2; M3, mouse 3. (C) Exemplar whole-cell Na+ current (INa) traces of atrial cardiomyocytes isolated from F1759A-dTG mice. Whole-cell current traces were recorded with 5 mM Na+ in both extracellular and intracellular solutions, in the absence (black) and presence (red) of 3 mM lidocaine. (D) Fraction of lidocaine-resistant current for littermate control. Mean ± SEM; n = 3 mice for each group, control and F1759A-dTG. M1, mouse 1; M2, mouse 2; M3, mouse 3. (E) Exemplar whole-cell Na+ current traces designed to assess persistent INa using a 190-ms depolarization from a holding potential of –110 to –30 mV in the absence (black) and presence (blue) of 500 μM ranolazine; intracellular solution contained 5 mM Na+ and extracellular solution contained 100 mM Na+. n = 3 mice; n = 54 cardiomyocytes. (F) Graph of extent of persistent INa. Mean ± SEM. n = 3 mice for each group, control and F1759A-dTG, **P < 0.05; 2-tailed Student’s t test. M1, mouse 1; M2, mouse 2; M3, mouse 3.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts